Metropolitan Life Insurance Company (MetLife)’s InfuSystem Holdings INFU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,003
Closed -$8.6K 1032
2024
Q1
$8.6K Hold
1,003
﹤0.01% 2182
2023
Q4
$10.6K Hold
1,003
﹤0.01% 2162
2023
Q3
$9.67K Hold
1,003
﹤0.01% 2223
2023
Q2
$9.66K Buy
+1,003
New +$9.08K ﹤0.01% 2315
2022
Q1
Sell
-5,378
Closed -$91.6K 2454
2021
Q4
$91.6K Hold
5,378
﹤0.01% 2532
2021
Q3
$70.1K Buy
+5,378
New +$87.7K ﹤0.01% 2701
2021
Q2
Sell
-3,873
Closed -$78.9K 2784
2021
Q1
$78.9K Buy
+3,873
New +$72.5K ﹤0.01% 2479

Other funds holding INFU

Metropolitan Life Insurance Company (MetLife)'s INFU Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of InfuSystem Holdings (INFU) in Q2 2024, closing a stake of 1,003 shares — an estimated $8.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in INFU in Q1 2021 and held it in 7 quarters. The position peaked at $91.6K in Q4 2021. 78 funds tracked by Wall St. Rank hold INFU as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining InfuSystem Holdings position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,003 InfuSystem Holdings shares in Q2 2024, an estimated $8.6K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in InfuSystem Holdings in Q1 2021 and held it in 7 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s InfuSystem Holdings position peaked at $91.6K in Q4 2021.
  • 78 funds tracked by Wall St. Rank held InfuSystem Holdings as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.